Phone number* Post code Email address* Select the Bodyline treatment that you would like to discuss* Women’s HRT Men's low testosterone Weight loss Health checks Low dose naltrexone By submitting this form you agree to the Bodylineprivacy policy....
original research low-dose naltrexone suppresses ovarian cancer and exhibits enhanced inhibition in combination with cisplatin 来自 万方医学 喜欢 0 阅读量: 37 作者:RN Donahue,PJ Mclaughlin,IS Zagon 摘要: Ovarian cancer is the leading cause of death from gynecological malignancies. Although initial ...
BACKGROUND: Low-dose naltrexone (LDN) has shown promise in several clinical studies as a safe and effective treatment for Crohn's disease (CD). Naltrexone is an opioid receptor antagonist. It acts as a competitive antagonist at several opioid receptor sites, showing the highest affinity for mu...
Some products that may interact with this drug are: pramlintide, MAO inhibitors (isocarboxazid,linezolid,metaxalone, methylene blue, moclobemide,phenelzine,procarbazine,rasagiline, safinamide, selegiline,tranylcypromine),naltrexone,potassiumtablets/capsules. ...